Santidrian Antonio Fernandez
Chief Scientific Officer · Calidi Biotherapeutics, Inc.
Individual
- 2025
- Aug 19, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Santidrian Antonio Fernandez files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Allan Camaisa - $1K in CLDI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Santidrian Antonio Fernandez?
Santidrian Antonio Fernandez is a corporate insider, tracked as Chief Scientific Officer of Calidi Biotherapeutics, Inc. (CLDI). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Santidrian Antonio Fernandez submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.